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Abstract 11 
As synthetic biology moves away from trial and error and embraces more formal processes, 12 
workflows have emerged that cover the roadmap from conceptualization of a genetic device to its 13 
construction and measurement. This latter aspect (i.e. characterization and measurement of 14 
synthetic genetic constructs) has received relatively little attention thus far, but it is crucial for 15 
their outcome. An end-to-end use case for engineering a simple synthetic device is presented 16 
which is supported by information standards and computational methods, and which focuses on 17 
such characterization/measurement. This workflow captures the main stages of genetic device 18 
design and description and offers standardized tools for both population-based measurement and 19 
single-cell analysis. To this end, three separate aspects are addressed. First, the specific vector 20 
features. Although device/circuit design has been successfully automated, important structural 21 
information is usually overlooked, as is the case of plasmid vectors. The use of the Standard 22 
European Vector Architecture (SEVA) is advocated for selecting the optimal carrier of a design 23 
and its thorough description, in order to unequivocally correlate digital definitions and molecular 24 
devices. A digital version of this plasmid format was developed with the Synthetic Biology Open 25 
Language (SBOL) along with a software tool that allows users to embed genetic parts in vector 26 
2 
cargoes. This enables annotation of a mathematical model of the device’s kinetic reactions 27 
formatted with the Systems Biology Markup Language (SBML). From that point onwards the 28 
experimental results and their in silico counterparts proceed alongside, with constant feedback to 29 
preserve consistency between them. A second aspect involves a framework for the calibration of 30 
fluorescence-based measurements. One of the most challenging endeavors in standardization, 31 
metrology, is tackled by reinterpreting the experimental output in light of simulation results, 32 
allowing us to turn arbitrary fluorescent units into relative measurements. Finally, integration of 33 
single-cell methods into a framework for multicellular simulation and measurement is addressed, 34 
allowing standardized inspection of the interplay between the carrier chassis and the culture 35 
conditions. 36 
Introduction 37 
Synthetic biology is concerned with the rational design and construction of biological 38 
information-processing devices
1
. The rigorous application of engineering principles and 39 
processes is fundamental to the success of this endeavor
2,3,4
. Significant attention is now being 40 
paid to the development of standardized workflows
5,6
 which describe sequences of biological and 41 
algorithmic processes required to obtain a desired outcome. Such workflows specify a tool-chain 42 
for synthetic biology. The anticipated benefits of using them include modularity (allowing 43 
individual processes to be implemented in several different ways), robustness and scalability.  44 
One of the over-arching challenges for the field is the end-to-end automation of biodesign
7,8
 a 45 
process that includes two main stages
6
: [i] the automatic selection and/or construction of 46 
biological components, and their assembly into a network that, in principle, performs information 47 
processing according to a high-level specification, and [ii] the fine-tuning of the system 48 
components and/or architecture to obtain the desired performance. The first part of this process 49 
concerns the detailed specification of the components to be used
9,10
 (or fabricated
11,12,13
), the 50 
attendant data representation and storage issues
14
 and the correct arrangement of components into 51 
a device/circuit that can implement a given (logical) function. A wealth of so-called bio-CAD 52 
tools now exist for this latter task
15,16
 e.g. SBROME
17,18
 TinkerCell
19
, SynBioSS
20
 and CELLO
21
. 53 
In terms of fine-tuning (the second stage), recent developments use post-assembly modification 54 
3 
of constructs based on observed network behaviour
6
 or the evolution of cell models
22
 facilitating 55 
an iterative homing-in approach towards genetic designs.  56 
The work presented in this article focuses on the latter stages of the device/circuit engineering 57 
process (that is, the implementation stages that follow the initial development of a given design). 58 
The specific issues addressed with the workflow discussed below include the formalization of 59 
device description regarding the sequences of the parts of the system to be constructed and the 60 
effect of plasmid vectors on performance. An early technical standard for the description of 61 
biological parts was the BioBrick
23,24
, which is appropriate for the assembly of DNA segments. 62 
However, a key consideration (which is virtually neglected by earlier standards) is the variety of 63 
plasmid vectors that are available for the deployment of biological devices. In reality, the choice 64 
of plasmid vector can dramatically affect the performance of a given device; plasmid features 65 
such as replication origin, selection markers and expression system need to be carefully selected
25
. 66 
Finally, the correlation of experimental observations vs. simulation results is addressed: As 67 
computational tools to aid biodesign become more commonplace, more uniform types of circuits 68 
are reported in the literature. However, once they are built, the process of measuring the behavior 69 
of the designed system (in order to assess its fidelity to the desired output) may still vary 70 
substantially. This is because few existing workflows consider measurement, and teams are free 71 
to choose their own tools for this mission. Mathematical and computational modeling have 72 
become fundamental tools in synthetic biology, but they are only effective when combined with 73 
useful in vivo observations of synthetic systems. In this context, the workflow reported below, 74 
describes a methodology for easily mapping simulation results onto laboratory measurements.  75 
Results and discussion 76 
Figure 1 shows the different stages of the workflow discussed in this article.  By adopting a 77 
combined experimental in vitro / in silico approach, the two perspectives become tightly coupled 78 
at key points. The various stages are ordered along time, from left to right, and they begin once a 79 
device design is established. Note that issues of design were not considered, and instead the 80 
workflow focuses on implementation and measurement. The first stage in the workflow is 81 
Description, in which the design of the desired construct is captured by some representation(s). 82 
4 
This then feeds into the Implementation stage, in which the construct is built (or modeled). Once 83 
the device has been implemented, Population-level measurement is carried out in order to obtain 84 
aggregate performance metrics. This then feeds into a second Implementation phase, which 85 
facilitates closer (single-cell) observations. These workflow stages are detailed as follows.  86 
Description 87 
In order to obtain reliable and robust performance of the device, it is of essence having control 88 
over the vector and being able to compare its performance with the same plasmid in multiple 89 
scenarios. In order to achieve this for the in vivo component the Standard European Vector 90 
Architecture (SEVA)
26
 was adopted. This is an active
27,28,29,30
 standard for the physical assembly 91 
of plasmid vectors and their nomenclature, as well as an online database of functional sequences 92 
and constructs available to the community. Along with the SEVA depiction of the plasmid there 93 
is a digital representation of the device/circuit for the in silico component of the workflow, for 94 
which the Synthetic Biology Open Language (SBOL)
31
 is used. This provides a standard 95 
exchange format for synthetic biology designs (between research groups, and between different 96 
toolkits).  97 
Implementation 98 
In the first in vitro Implementation phase, the vector is assembled using standard Molecular 99 
Biology procedures. This results in the synthesis of DNA segments, which are then inserted into 100 
the carrier plasmid. In parallel with this process (i.e., during the in silico implementation phase), 101 
a standardized digital description using SBOL is constructed, with one SBOL document per 102 
genetic construct (Supplementary File S2). These documents are then combined (using a Java-103 
based tool; Supplementary Tool S1), resulting in a single SBOL file containing the sequences of 104 
interest in the correct cargo position according to the restriction enzyme sequences. This tool 105 
identifies those SBOL components that are common across components (i.e., the restriction sites) 106 
and replaces all the information that exists in the cargo section from restriction site to restriction 107 
site with the functional cassette of interest. After this step, both the plasmid containing the device 108 
and its representation are fully standardized. Note that the cassette to be inserted into the cargo 109 
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section may be assembled (using any wet technique) or synthesized; the restriction sites of the 110 
SEVA vectors can be used in this Implementation stage or in possible post-measurement 111 
debugging. 112 
Measurements 113 
The use of mathematical modeling and computational analysis has become a fundamental part of 114 
synthetic biology, due to the information they provide concerning the mechanical behavior of the 115 
systems. However, this potential can only be used effectively when combined with direct in vivo 116 
measurements
32
. This is helped by ongoing advances in metrology (see, for instance, the TASBE 117 
tools at https://synbiotools.bbn.com). Recently, attempts have been made to standardize e.g. 118 
Relative Promoter Units (RPU)
33
 as a measuring standard for promoter activity based on a 119 
comparison against a reference promoter. On a more abstract level, the Polymerase Operations 120 
Per Second (PoPs) measure
9
 is abstracted as the signal carrier in transcriptional devices. However, 121 
none of these methods are free of controversy
15
.  122 
In order to simulate the model constructed in the Implementation phase, the iBioSim
34
 tool was 123 
used. Conveniently, iBioSim exports reactions to a single Systems Biology Markup Language 124 
(SBML)
35
 file (Supplementary File S3), which is a computational standard for the representation 125 
of biochemical networks. Importantly, this allows linking up the SBML biochemical model of the 126 
device with the SBOL description of its DNA components, using the methodology described by 127 
Roehner and Myers
36
 (Supplementary File S4). In turn, this connects (via SBOL) with the SEVA 128 
description of the vector, giving seamless integration of information across different standards 129 
that are used for different levels of description. An additional application was developed 130 
(Supplementary Tool S2, based on libSBML
37
) for converting a given SBML file into Python 131 
coded scripts, used for for deterministic and stochastic simulations (Supplementary File S5). 132 
Importantly, the SBML model details (i.e., rates) correspond not only to the device itself, but also 133 
its carrier vector. This significantly reduces output variability: by including details of the vector 134 
in the model characterization (via SEVA/SBML), the possibility that the carrier plasmid might 135 
later change due to decisions taken at the implementation phase is considered. Any such change 136 
will, in turn, inevitably (although, sometimes subtly) affect the observable behavior of the model 137 
6 
when implemented. Including details of the vector thus allows to ponder fluctuations due to 138 
variable plasmid selection. 139 
The inclusion of an extra step within the workflow for multicellular analysis also helps reducing 140 
the variability caused by both the chassis and the culture conditions, as they add their own effects 141 
to the construct and its carrier. If the device has to be used under different scenarios, the cellular 142 
behavior should be quantified. There are behaviors in the example provided, that cannot be 143 
measured with the cytometer (i.e., noise inheritance or cell movement), and which require time-144 
lapse microscopy in order to be quantified. The parameters corresponding to these behaviors are 145 
therefore fitted according to single-cell measurements. Again, this information adds value to a 146 
potential specification sheet that accompanies the in vivo system.  147 
Spectophotometry is used to measure the fluorescent signal of the entire cell population; dividing 148 
this by the optical density at 600 nm (OD600) over time yields the average fluorescence value per 149 
cell in the culture. Experimental values are used to fit kinetic rate parameters in the mathematical 150 
models so they produce similar profiles. Importantly, in the graphs that follow, the Y-axis refers 151 
to arbitrary units of fluorescence in experimental observations, and the number of molecules (for 152 
example, mCherry proteins) in the simulated observations. Matching the latter with the former 153 
gives an important reference point concerning measurements, which allows interpretation of 154 
subsequent results.  155 
Stochastic analyses are then done in order to characterize noise in the system, using the well 156 
established Gillespie algorithm
38
. On the experimental front, data on noise is obtained using flow 157 
cytometry, which allows user to check the fluorescence intensity value of (in principle) every 158 
single cell in the bacterial culture. Although the ready-to-use graphs produced by the cytometer 159 
(Supplementary Figure S1) are used as standard in most laboratories, raw values were preferred 160 
before they are processed for presentation (normally in a black box fashion, which is opaque to 161 
the user). There are three main reasons for using raw cytometry data: [i] Cytometers count cells 162 
using variable intervals of fluorescence at high values of a logarithmic scale that is not always 163 
constant, and which depends on a specific machine set-up. This processing therefore introduces 164 
variability that is hidden from the user; [ii] cell-specific values are needed in order to make direct 165 
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comparisons with simulated cells within our framework; (3) raw data values are more amenable 166 
to importing and processing by various tool-chain components. In contrast, automated extraction 167 
of specific values from graphs produced by cytometers introduces unnecessary complications and 168 
the possibility of misreading data. 169 
A simulated cytometry graph is obtained by running the Python version of the reactions (see 170 
Methods). This offers two potential benefits. On one hand, it gives a computational method (via 171 
an SBML model) of discarding invalid values from the raw cytometry information (see the later 172 
Case study for an example). On the other hand, by overlapping both experimental and simulated 173 
plots the arbitrary units (au) of the cytometer and those from the spectrophotometer could be 174 
correlated. This procedure seems therefore to help unifying machine-based measurements in the 175 
Laboratory, as shown in the case study below.  176 
Implementation 177 
The behavior of the device under study is inevitably affected by the specific attributes of the host 178 
cell. A thorough characterization of a construct should, therefore, include information about the 179 
performance of the chassis
39
 (which, in the case shown, is E.coli CC118
40
). Rather than simply 180 
providing added value, this information is of vital importance in the case of multicellular 181 
applications
41,42
, which are becoming increasingly important as cell-to-cell communications are 182 
increasingly well-understood and customised
43,44
.  183 
In order to study the behavior of devices in vivo the DiSCUS
4
 package previously developed to 184 
study bacterial growth was adopted as an agent-based simulation tool. Importantly, this platform 185 
considers physical forces between rod-shaped bacteria and is applicable to a wide range of 186 
organisms. DiSCUS uses the previously generated Python scripts for the intra-cellular genetic 187 
network that is implemented in the cells of interest. The SBML model is therefore embedded into 188 
the cellular objects of the agent-based simulator. Note that there is a standard, currently under 189 
development, called the Multi-Cellular Data Standard (MultiCellDS, http://multicellds.org/), 190 
which aims at sharing multicellular experimental, simulation and clinical data. Hopefully, when 191 
released, it will facilitate partaking of configuration parameters for a specific chassis performance. 192 
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In the case under examination (see below), a 2-dimensional culture was prepared on an agarose 193 
pad
46
, and the cells let to grow on a monolayer in order to facilitate visualization in the 194 
microscope.  195 
Single-cell measurements 196 
The movement and the growth of the simulated cells were first calibrated according to 197 
experimental observations. For this, the successive positions of a specific cell until division were 198 
monitored and the displacement of its offspring during their lifetime(s) followed. These results 199 
were matched against the equivalent information obtained from the simulations, and adjusted to 200 
DiSCUS parameters for fitting the experiments. In short (see Methods for more details), this 201 
information yields the most relevant features to prioritize in DiSCUS in order to reproduce the 202 
movement of the cells in vivo (see example below).  203 
Spatial measurements 204 
After characterizing the dynamics of the chassis that host the construct, its performance in a 205 
spatial scenario was measured. For this, we quantified the fluorescence intensity of the device in 206 
vivo, and obtained a pixel-based image analysis of the specific color (red in the example,) 207 
captured by the microscope. The ensuing analysis translates the scale bar into values proportional 208 
to those used in the mathematical model (see Methods for details of this conversion). As a 209 
consequence, a simulation run with the system’s equations inside DiSCUS bodies, could be 210 
directly compared with experiments in respect to device function.  211 
Case study 212 
A combined in vivo/in silico study involving a simple construct was picked as an informative 213 
example of the proposed workflow. The starting point was an always-on gene expression device 214 
i.e. a genetic module enabling constitutive transcription and translation of a reporter gene 215 
(mCherry; Figure 2A). Although this setup involves just a few components, it was also 216 
instrumental to highlight the main focus of this work, which lies on the measurement of such 217 
devices. That is, the complexity of the device to be constructed is less critical than the 218 
9 
management of its output. Given that fluorescence measurements are taken in fundamentally in 219 
the same way, regardless of the size or complexity of a synthetic device, the question at stake is 220 
how such metrics might be standardized, and relate them back to in silico studies in a useful and 221 
meaningful way. 222 
As shown in Figure 2A the two subcomponents of the device were [i] the pEM7 constitutive 223 
promoter, and [ii] the red fluorescence reporter gene mCherry (see Methods for details; 224 
Supplementary File S1). Once the initial design was in place the system was taken to the 225 
Description stage, where pEM7-mCherry was digitally formalized and physically built. The  226 
pSEVA231 vector (Figure 2B) was selected to implement the design. This plasmid contains a 227 
kanamycin marker, an origin of replication pBBR1, and the default cargo segment. As the cargo 228 
segment is a sequence of restriction sites, specific locations have to be selected for inserting the 229 
desired parts. As shown in Figure 2A, the promoter component was flanked by restriction sites 230 
PacI and AvrII, while HindIII and SpeI were chosen for the reporter gene –thereby leaving a 231 
number of empty sites in between for a possible future usage.  232 
Once the Description phase was complete, the system was taken to the Implementation stage. 233 
Figure 3A highlights the kinetic rates involved and the Ordinary Differential Equations (ODEs) 234 
that govern the continuous functioning of the always-on device. After cloning, Figure 4A 235 
shows the results for average fluorescence value per cell in the culture, along with 236 
deterministic simulation runs (based on the ODEs) for both the SBML model (implemented 237 
using iBioSim) and its corresponding Python script. The stage was thus set to move to the 238 
Population measurement phase.  239 
Figure 4B shows the fluctuations in molecular levels of the reactions of Figure 3A when running 240 
the Gillespie algorithm on the SBML model (iBioSim) and its corresponding Python file. As 241 
expected, the observed variability was the same in both, as the kinetic rates remain unchanged 242 
(i.e., the same as in the ODEs). The mean value was precisely situated on the steady state value 243 
of the deterministic simulation. Raw data from the cytometer are plotted on Figure 4C, where the 244 
bimodal curve indicates that approximately half of the cells displayed a strong fluorescence, 245 
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while the rest expressed none (or very little). The latter group corresponded to invalid values, and 246 
could be discarded, as indicated by the control data (the same strain without the plasmid) and the 247 
already processed graph (Supplementary Figure S1). Moreover, further microscopy tests showed 248 
strong fluorescence in all the cells with a relatively narrow noise interval, which confirms the 249 
correct elimination of that non-expressing cell group. As described in the workflow description, 250 
this gives a computational standard way of discarding invalid values from raw cytometry 251 
information. Moreover, it yields a method for correlating outputs from different pieces of 252 
laboratory equipment. We illustrate this in the graph of Figure 4C, showing that Arbitrary Units 253 
(au) of the cytometer could be correlated with those from the spectrophotometer: 1 au in the 254 
former, and ≃ 1.2 au in the latter (see Methods for details).  255 
After performing population-level measurements, the workflow proceeds to single-cell 256 
measurements. Figure 5A shows the result of experiments to track cell movements. Figure 5B 257 
shows the positions of a bacterium (from Figure 5A) until division, and then the displacement of 258 
its daughter cells during their lifetime. Figure 5C shows the most relevant features needed for 259 
adding to DiSCUS in order to reproduce the movement of the bacteria, starting from a very 260 
simple growth algorithm (which returns unrealistic patterns; Figure 5C.1). Ultimately, the 261 
qualities to be considered include [i] cell size variations (due to conditional growth), [ii] changes 262 
in transversal angles after division, [ii] randomised directions of movement, and [iv] slight 263 
attraction between cells (in order to avoid the appearance of holes within the colony).  264 
Figure 5D compares the synchrony of growth within experimental and simulated cells, yielding 265 
suggestions as to how to uncouple growth events. These graphs show the length of each cell in 266 
the population over time (in Laboratory experiments) or iterations (in the simulation). Starting 267 
with just two cells (the same setup as in Figure 5A) that grow and divide at the same time it 268 
becomes apparent that the length of the cells is no longer synchronized after the second division 269 
(eight cells in total).  270 
The spatial scenario is considered next. Figure 6A shows the results of measuring the 271 
fluorescence intensity of the pEM7-mCherry device when placed in the E. coli CC118 strain 272 
along with a pixel-based image analysis of the red color captured by the microscope. As indicated 273 
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above, the scale bar of the analysis was translated into values proportional to those of the 274 
mathematical model of Figure 4B. A simulation run in DiSCUS, using the system’s equations 275 
(Figure 6B, left) can be directly compared against experiments. For instance, its it possible to 276 
verify that daughter cells share output levels as they directly copy their mother’s device at a given 277 
time (Figure 6B). Also, that cells with slower growth tend to display a stronger light signal (due 278 
to the accumulation of fluorescence proteins).  279 
Conclusion 280 
Development of standardized workflows that allow for robust and reproducible genetic constructs 281 
is one of the contemporary challenges of synthetic biology. The frame presented above 282 
contributes to this endeavor by setting both computational and experimental approaches to build 283 
and measure synthetic devices, using a simple synthetic device as an example. This approach is 284 
different and complementary of other efforts that focus on specific steps e.g. automated circuit 285 
design
5,16,18
, mathematical modelling
20
, single-cell analysis
46
, metrology
33
, data representation
31
 286 
or post-construction modification
6
. In contrast the workflow presented in this article can make 287 
use of several of them by concentrating on output measurements, what is ideal for design-288 
oriented efforts. While the literature records other workflow propositions
15
, they tend to focus on 289 
enumeration rather than application of techniques. Instead, the tools presented here allow linking 290 
standards, e.g. merging SBOL documents for SEVA description, or the scripts to translate SBML 291 
into Python. The system will hopefully provide a useful starting point for newcomers to the field, 292 
as well as (more generally) a standard workflow for robust programming of biological systems. 293 
Materials and Methods 294 
Strains and plasmids. The E. coli strain used in this work was CC118
40
. The vector plasmid for 295 
the expression device was pSEVA231 (kanamycin resistance, pBBR1 origin of replication and 296 
default SEVA cargo) selected from the database http://seva.cnb.csic.es/. pEM7 promoter was 297 
cloned in pSEVA231 as a PacI/AvrII fragment and the mCherry reporter gene as a HindIII/SpeI 298 
DNA segment. The resulting plasmid was named pSEVA237R-pEM7 (available in the SEVA 299 
12 
database). An important aspect is that sequences of interest encoding the expression device were 300 
edited to remove any restriction site incompatible with the SEVA standard. 301 
SBOL-SEVA description. The SEVA format is highly structured in unambiguous functional 302 
segments, as shown in Figure 2B. The SEVA vector 231 was described using SBOL-2.0
47,48
, 303 
(Supplementary Figure S2). The previous description of this vector using the GenBank format
49
 304 
was improved by adding missing features (e.g. assembly scars), and by establishing structural and 305 
functional links. Two more SBOL documents were produced, one for each component of the 306 
device. Ultimately, a Java based application was developed that could be fed with the carrier 307 
plasmid and the cassettes that need to be inserted, and outputs the composite vector. The 308 
application searches in the carrier file for those restriction sites present in the cassettes (iteratively) 309 
and replaces the sequence in between. The resulting SBOL document has all location parameters 310 
(i.e. bioStart) updated.  311 
Mathematical modelling and SBML-to-Python conversion. In the model of Figure 3A, we 312 
show the promoter-reporter pair (18 copies, as estimated by previous observations for pBBR1 313 
origin of replication
50
), mRNA the messenger RNA and rfp, the red fluorescent protein (both at 0 314 
molecules at the beginning of the simulation). Regarding the kinetic rates: k1 is the transcription 315 
rate (27/18 hour
-1
 from each plasmid), k2 represents the translation rate (2.5 hour
-1
), k3 the 316 
degradation rates of the mRNA (0.65 hour
-1
) and k4 the protein degradation rates (0.265 hour
-1
). 317 
Note that for such a small network, parameter assignment is non-trivial due to the number of 318 
constraints. The effort for assigning numbers to rates
51
 is thus of vital importance at this stage. 319 
The software iBioSim (http://www.async.ece.utah.edu/iBioSim/) was then used to write the 320 
model in SBML format and run the simulations with the Hierarchical Runge-Kutta method for 321 
ODEs solution, along with the Gillespie algorithm for stochastic behavior. The model was 322 
exported in a flat (iBioSim option) XML file and converted into Python scripts with the tool 323 
provided (Supplementary Tool S2). Flow cytometry data was obtained from the FCS files 324 
without processing, and the simulated graph was obtained by [i] sampling a stochastic run in time 325 
(forcing equal time intervals), [ii] counting intensity values over a long enough (~ 600 hours) 326 
period and [iii] reinterpreting x-axis values (originally, time) as individual cells in order to 327 
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represent an intensity distribution comparable to the experimental plots. By making the 328 
simulations match experiments (Figure 4A), its appeared that ~ 400 simulated molecules (s.m.) 329 
corresponded to ~ 400 arbitrary units in the spectrophotometer (a.u.s). As the computational 330 
measurements (s.m.) in the stochastic simulation are exactly the same, they were correlated 331 
with the fluorescent units of the cytometer (a.u.c). As Figure 4C shows, ~ 400 s.m. = ~ 330 332 
a.u.c; therefore 1 a.u.s = 400/330 a.u.c. We assume that the sources of fluorescent signal are 333 
the same, as the cells remained unaltered.  334 
Two-dimensional in-vivo setup. Samples for the microscope were prepared with agarose pads 335 
on a slide glass with an attached frame (1.7 X 2.8 cm, Life Technologies) following the method 336 
described by de Jong et al.
52
 To this end, 500 µl of LB, including 2% of melted agarose was 337 
added into the middle of the frame and assembled with another slide glass. After 30 min at room 338 
temperature, one of the slide glasses was carefully removed, maintaining an intact agarose pad. 339 
Then, the pad was cut out to 5 mm width within the frame using a razor blade and two strips of 340 
the pad used for supporting growth of the bacterial cells. For this, strain carrying pSEVA237R-341 
pEM7 was pre-cultured overnight in LB at 37º C, diluted 100-fold in the same medium and 342 
grown to exponential phase (OD600 = 0.2). 2.5 µl of the samples were then spotted on to the 343 
agarose pad and assembled with cover glasses (24 x 50 mm) for further analysis. Widefield 344 
fluorescent microscopy was used to observe the samples (Leica DMI6000B, Leica 345 
Microsystems) with a digital CCD camera Orca-R2 (Hamamatsu). Cell growth was monitored 346 
for 75 min under the microscope at 37º C and images were captured every 3 min with 347 
a40.0x/0.75 NA dry objective or a 63.0x/1.3 NA glycerol immersion objective (depending on 348 
the experiment) with a bandpass filter for mCherry (BP 560/40 and EM 645/75.) using the 349 
LAS AF v. 2.6.0 software (Leica Microsystems). Images were analyzed with the MATLAB-350 
based code Schnitzcells53 in order to track both the positions of the cells and their length 351 
while growing.  352 
Two-dimensional in-silico setup. DiSCUS (http://code.google.com/p/discus/) is an agent-based 353 
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software for bacterial growth that uses Pymunk (http://pymunk.readthedocs.org/en/latest/), a 2D 354 
physics library, to resolve collisions among cells. In the most basic test of Figure 5C.1 each cell 355 
is a body of 16x30 square lattice that grows lengthwise until division, when the cell is cut in half. 356 
Pressure-based growth is simulated by counting the cells that push a body of interest (threshold at 357 
4 cells) and slowing down the growth events (without stopping them). Random angle variations 358 
were introduced after division, whereby the daughter cells copy the angle of the mother and add a 359 
number in the interval (-25,25) degrees. Furthermore, angle variations were included at the 360 
normal growth events, although to a smaller extent (maximum variation of 5 degrees). The fact 361 
that the cells grow in vivo forming a circular group without holes was simulated using a slight 362 
gravity-like value that pushed the cells towards the middle of the population. This force can be 363 
eliminated when the population is about 20 cells big, at which point the circular shape is 364 
conserved without any other attraction.  365 
Regarding pixel intensity in the analysis of Figure 6A, the maximum value was set to be at the 366 
same level as the highest peak of the stochastic simulation of Figure 4B or the cytometry data of 367 
Figure 4C (~ 470 a.u.). Therefore we calculated the percentage rate (470 times 100 divided by the 368 
maximum pixel value) to convert the intensity of every pixel into the scale shown by experiments. 369 
Again, we assume that the source of light is the same (E.coli CC118) and variances are due to 370 
different machine measurements.  371 
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Supporting Information Legends 511 
Supplementary File S1. Sequences of promoter pEM7 and gene mCherry. 512 
Supplementary File S2. SBOL files. For a) plasmid, b) promoter and c) reporter.  513 
Supplementary Tool S1. Software tool to merge SBOL files and insert cassettes into a vector.  514 
Supplementary File S3. SBML files.  515 
Supplementary File S4. Annotated SBML file.  516 
Supplementary Tool S2. Software tool to convert a SBML model into a Python script.  517 
Supplementary File S5. Python scripts  518 
9 Supplementary Figure S1. Cytometry results. Graph output by cytometer after processing.  519 
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Figures 521 
 522 
Figure 1: Workflow for an end-to-end synthetic biology use case. The description that follows 523 
(and modifies) the design of an idea is the starting point for the consequent experimental and 524 
computational methods. The device and its carrier vector are described using the SEVA 525 
(Standard European Vector Architecture) format for the in vivo workflow and the SBOL 526 
(Synthetic Biology Open Language) standard for the parallel in silico process. A first 527 
implementation round is then performed via synthesis and cloning methods in the wet-lab and via 528 
SBML (Systems Biology Markup Language) for the modeling. The resulting material is then 529 
used for different measurements. First, laboratory equipment is used for population-based 530 
experiments (spectophotometry and flow cytometry) to compare the output against simulation 531 
software (iBioSim and ad hoc python code). Another implementation round prepares the samples 532 
for single-cell measurements. On the computational side, the SBML model is exported to a 533 
Python script ready to be used with the software for cell movement DiSCUS (Discrete Simulation 534 
of Conjugation Using Springs). On the other side, the cells are grown on an agarose pad for 2-535 
dimensional populations that allow matching results.  536 
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                                                                                                                                                    537 
Figure 2: SBOL description of device and SEVA components. A. Design modification where 538 
the components are flanked by the selected restriction sites that specify their situation inside the 539 
SEVA vector. The constitutive promoter pEM7 is surrounded by PacI and AvrII sites, whereas 540 
the reporter mCherry is flanked by HindIII and SpeI. An SBOL document per component is 541 
created. B. The plasmid selected to harbor the device is SEVA number 231 (kanamycin 542 
resistance, pBBR1 origin of replication, default cargo). All vector features are recorded in a 543 
single SBOL document, including the cargo (multiple cloning site) component for a further 544 
assembling of device-forming parts. C. Both in vivo and in silico protocols for building the final 545 
construct have the same basics i.e. introducing parts sequentially in the carrier vector. A software 546 
tool (Supplementary Tool S1) allows to do so with SBOL documents.  547 
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 548 
Figure 3: Mathematical modeling and its SBML format A. Kinetic reactions (up) and system’s 549 
differential equations (bottom). The device’s behavior can be effectively simulated with just four 550 
kinetic constants: the constitutive promoter P facilitates reporter transcription with rate k1, 551 
resulting mRNA is translated with rate k2 leading to the formation of RFP (red fluorescent 552 
protein) and both elements are degradated with rates k3 and k4 respectively. ODEs (Ordinary 553 
Differential Equations) governing continuous dynamics are shown. B. Scheme of the SBML 554 
model produced with the software iBioSim, a CAD (computer-aided design) package for systems 555 
biology. In the screenshot, blue elements represent substrates and red circles hide reaction rates. 556 
After setting the parameters, iBioSim allows the user to export the model to an XML file 557 
formatted following the SBML standard.  558 
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                                                                                                                                                    559 
Figure 4: Population-based measurements in experimental and simulation setups. A. 560 
Deterministic functioning of the device, in terms of fluorescence intensity over time (during 14 561 
hours), averaging the value of the whole population. Red line corresponds to experimental results, 562 
while blue and black lines show simulation runs of the model’s differential equations with 563 
iBioSim and Python code respectively. Experimental values were used to fit rate numbers in 564 
mathematical models so they produce similar continuous lines. B. Stochastic behavior of the 565 
system according to simulations. The blue line results of running the Gillespie algorithm with 566 
iBioSim whereas the black line shows the python script behavior. As expected (same algorithm 567 
with equal parameters), the fluctuations are alike. C. Fluorescence intensity values of each cell in 568 
the population measures variability and expression noise. Experimental raw data extracted by 569 
flow cytometry (without processing by the cytometer, see text for details) corresponds to the red 570 
line. Black line results from counting expression values in the simulation with the Python script, 571 
while grey area represents the control (plasmid-free cells) measured experimentally. Note that 572 
scales are different in simulation and experimental lines, standing for variability within arbitrary 573 
units (a.u.).  574 
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 575 
Figure 5: Characterization of chassis mechanics. A. Tracking cell lineages in an experimental 576 
setup. Starting from the division of a single cell (up) the movement of its daughters were 577 
followed (middle and bottom) in order to define their movement behavior until next division. B. 578 
Position coordinates are recorded during the experiment (red line) and simulation (black line) to 579 
fit parameters by comparing both outputs. Cell traces are overlapped for visualization purposes 580 
and axis rotated accordingly to show dimensions. C. Parameter estimation for cell movement. 581 
Different features are included, sequentially, in order to get the final moving procedure for in 582 
silico simulations. Starting from inaccurate movement (C.1) we add size variability due to 583 
pressure (C.2), random angles after division (C.3), irregular motion changes (C.4) and slight cell 584 
attraction to simulate viscous bodies (C.5). All simulations start from a single cell, and one 585 
lineage is colored to monitor coordinate positions. D. Synchrony of cell growth. The length of 586 
each cell (y axis) is monitored over time (x axis) in both scenarios (experiment, up; simulation, 587 
bottom). The initial cells grow at the same time until division point is reached, whereas the third 588 
generation of cells grow asynchronously.  589 
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 590 
 591 
Figure 6: Spatial progress of the genetic device. A. Phase contrast image of population (left), 592 
fluorescent picture (middle) and computational analysis (right). In the latter, the color scheme 593 
(right bar) represents the value of the red channel of every pixel from 0 to 255. However it is 594 
transformed into a [0,450] scale in order to allow comparisons with previous fluorescence 595 
measurements. B. On the left, a simulation of a colony starting from a single cell is shown. 596 
Upper-left arrow highlights cells with slower growth rate and RFP accumulation while bottom-597 
right arrow points at a recently divided cell where both daughters share similar RFP 598 
concentration. On the right, expression noise inheritance is indicated with an arrow. Furthermore, 599 
RFP accumulation caused by slow growth can be observed by the black line separation: a single 600 
cell started from each side.  601 
